13 results
Venous Thromboembolism Prophylaxis - Pharmacology Comparison Table

UFH vs Enoxaparin vs Fondaparinux

#VTE #DVT #Prophylaxis #Pharmacology #Comparison #Table
Venous Thromboembolism ... Pharmacology Comparison Table ... Fondaparinux #VTE #DVT ... Pharmacology #Comparison #Table
Phlegmasia Cerulea Dolens - In phlegmasia alba dolens, the thrombosis involves only major deep venous channels
only major deep venous ... The venous drainage ... present; the lack of venous ... #Clinical #EM #IM ... Cerulea #Dolens #DVT
HERDOO2 score to identify women with unprovoked venous thrombosis (VTE) at low risk of recurrent venous
with unprovoked venous ... risk of recurrent venous ... al #Management #IM ... PrimaryCare #HERDOO2 #DVT
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
#PrimaryCare #EM ... #IM #Differential ... Lightheadedness #Table
Differential Diagnosis of Jaundice, Presentation Pattern #Diagnosis #EM #IM #GI #Jaundice #Pattern #LFTs #Workup #Table #Differential
Pattern #Diagnosis #EM ... #IM #GI #Jaundice ... #LFTs #Workup #Table
Catecholamine Vasopressor Effect Sites and Indications #Pathophys #Management #EM #IM #PCC #Catecholamine #Comparison #Table #Epi #Norepi
Pathophys #Management #EM ... #IM #PCC #Catecholamine ... #Comparison #Table
Table of Common Rate Control Agents via AHA/ACC/HRS Guidelines #Management #Pharm #EM #IM #Cardiology #Afib #Common
Table of Common ... Management #Pharm #EM ... #IM #Cardiology ... #RateControl #Table
Original and Simplified PESI PulmonaryEmbolism #Diagnosis #EM #IM #PCC #PESI #sPESI #risk #score #PE #Table
PulmonaryEmbolism #Diagnosis #EM ... #IM #PCC #PESI ... risk #score #PE #Table
A quick infographic on various pearls about atopic dermatitis, a disease with an increasing burden on
Petersen EBM, Skov ... EL, Richardson IM ... of "wet wraps" versus
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

https://www.nejm.org/doi/full/10.1056/NEJMoa1711948

Authors’ Conclusions: “Oral edoxaban was noninferior to subcutaneous dalteparin
Cancer-Associated Venous ... outcome of recurrent venous ... rate of recurrent venous ... VenousThromboembolism #VTE #EBM ... VisualAbstract #DVT